Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis
- 31 May 2006
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 44 (5), 864-868
- https://doi.org/10.1016/j.jhep.2006.01.024
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology, 2001
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CHepatology, 2001
- Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis CAnnals of Internal Medicine, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CThe New England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CThe New England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- Clinical Outcomes after Transfusion-Associated Hepatitis CThe New England Journal of Medicine, 1995